LEAP2 and obesity disorder: Additionally, neurological dysfunction of the liver-expressed antimicrobial peptide 2 (LEAP-2) and its effects on the ‘hunger hormone’ ghrelin have also been highlighted as possible contributors towards the development of obesity.